Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04159740 · ClinicalTrials.gov registry record
Microbiome and Immunologic Analysis - Women With Endometriosis
A clinical trial of Endometriosis, sponsored by Mayo Clinic.
- Completed
- Registry status
- 48
- Enrollment target
- 1
- Study location
NCT04159740: Completed study of Endometriosis, sponsored by Mayo Clinic.
NCT04159740 is a study of Endometriosis that has completed, run by Mayo Clinic. The registered enrollment target is 48 participants, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04159740, a study of Endometriosis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this study is to assess differences in the microbiome between women with and without endometriosis. A second goal of this study is to assess immunologic differences between the eutopic (within the uterus) and ectopic (outside of the uterus) endometrial tissue in women with endometriosis. In order to investigate these areas of interest, 25 women with endometriosis and 25 women without endometriosis will be enrolled. All women will be undergoing a previously scheduled surgical procedure at which time presence or absence of endometriosis will be confirmed and specimens will be obtained.
Conditions Studied
Interventions
- OTHER Tissue and blood collection
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2020-02-06 |
| Est. Completion | 2022-03-11 |
What the finished NCT04159740 record still lists
NCT04159740 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 1 intervention - of which Tissue and blood collection is the first listed.
NCT04159740 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04159740 about?
NCT04159740 is a clinical study titled "Microbiome and Immunologic Analysis - Women With Endometriosis". The primary goal of this study is to assess differences in the microbiome between women with and without endometriosis. A second goal of this study is to assess immunologic differences between the eutopic (within the uterus) and ectopic (outside of the uterus) endometrial tissue in women with endom...
What is the current status of trial NCT04159740?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2020-02-06. Estimated completion is 2022-03-11.
What conditions does trial NCT04159740 study?
This clinical trial studies the following conditions: Endometriosis.
What interventions are being tested in trial NCT04159740?
The interventions under investigation include: Tissue and blood collection (OTHER).
Who is sponsoring clinical trial NCT04159740?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04159740 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04159740's enrollment target sits among peer trials
48 38th of 48 higher than 11 of 48 other Endometriosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometriosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Thromboxane Function in Women With Endometriosis
RECRUITING · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
-
The Impact of Yoga on Endometriosis-Related Pain
RECRUITING · NA
-
Endometriosis and Microvascular Dysfunction: Role of Inflammation
RECRUITING · Early Phase 1
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
-
Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI